CLINICAL_TRIALS
trial_result
· 2025-03-03
Clinical Trial Update: Efficacy of Albumin Dialysis to Treat Patients With Hepatic Encephalopathy Using The Molecular Adsorbent Recirculating System (MARS) [NA]
Summary
A completed clinical trial evaluated the efficacy of albumin dialysis using the MARS system to treat hepatic encephalopathy in patients with liver failure.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Vantive Health LLC | Conditions: Hepatic Encephalopathy, Liver Failure | NA | Status: COMPLETED